ContinuumRx Gives Patients the Tools to be Warriors Against Their Afflictions

Having an inflammatory bowel disease affects more than just what you eat. Patients can feel isolated, overwhelmed, and nervous about public appearances due to their afflictions. When you have Crohn’s disease or ulcerative colitis, canceling plans and missing out on milestones with family and friends can feel like just another consequence of your disease. ContinuumRx will help you manage your symptoms and make your condition a part of your life, not the center of your life.

What are Crohn’s disease and ulcerative colitis?

Crohn’s disease is a type of inflammatory bowel disease (IBD) that explicitly affects the gastrointestinal tract (GI). In a Crohn’s patient, the GI becomes inflamed and causes chronic, extreme pain. While this disease mainly affects the small intestine, patients may also report discomfort in the eyes, skin, and joints. 

The onset of Crohn’s can occur at any age, and it is still unclear why these symptoms present themselves in specific individuals. However, one hypothesis may point to it being a hereditary condition. According to, up to 20% of all Crohn’s patients have a direct relative with an IBD. 

Ulcerative colitis, also referred to as colitis, is similar because it is an IBD as well. While Crohn’s can affect the entire GI tract from mouth to anus, colitis is specific to the large intestine and rectum. 

With colitis, patients will also experience pain-inducing inflammation. As opposed to Crohn’s, where the inflammation can appear in sporadic patches throughout the GI and can spread through the bowel wall, colitis patients usually have inflammation of the entire colon and intestine’s inner lining.
The Crohn’s & Colitis Foundation estimates that nearly 780,000 Americans currently live with Crohn’s disease, while another 907,000 have colitis. There is no cure for either condition, but patients can experience relief from the symptoms and even remission with certain drugs.

What infusion therapies can help patients with Crohn’s and colitis?

Infusion therapy has been shown to improve the symptoms of Crohn’s and colitis significantly. Two types of infusion therapies that ContinuumRx uses to treat our patients from home are Remicade and Entyvio.

Remicade, also known as infliximab, is an infusion drug formulated to treat not only Crohn’s and colitis but also rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.

Infusion patients are given Remicade intravenously every eight weeks, and treatments usually last one to two hours. Remicade works by attacking a protein known as tumor necrosis factor, which medical professionals believe to be the element that triggers inflammation in Crohn’s disease. There’s no way to tell how long after treatment patients will see relief from their symptoms, but for many, it’s within the first six weeks after infusion therapy.

Entyvio, or vedolizumab, is an infusion medication used to treat Crohn’s and colitis exclusively. Treatment with Entyvio is similar, where patients are infused every eight weeks. However, the treatment duration is only about thirty minutes. Also with Entyvio, patients will see relief from symptoms in the first six weeks approximately. 

Entyvio works differently than Remicade as well. Instead of attacking inflammation-causing factors within the body, Entyvio binds to specific molecules and blocks these inflammatory factors; this, in turn, motivates anti-inflammatory gut activity. This type of symptom relief is possible since Entyvio is an IgG1 monoclonal antibody, meaning it is a unique white blood cell clone.

What benefits does receiving these infusion treatments from home have?

As we know, infusion treatment can be life-changing, but having to undergo infusion therapy has the potential to severely disrupt life for not just the patient but their families as well. Infusion sites and hospitals can be hours from your home, and the cost for travel and time will add up significantly. 

When compared to a hospital setting, home infusion is also the more cost-effective option. In a 2016 study published by the National Library of Public Medicine, it was found that home infusion could save patients between $1,928 and $2,974 per treatment course. 

ContinuumRx offers our patients the chance to receive Remicade and Entyvio infusions from home, eliminating the need for excessive travel and costs. Our medical professionals coordinate with physicians to onboard your therapy and make sure you are set up with the right equipment, nurse, and anything else you need to receive Remicade and Entyvio from any room in your house.

Crohn’s and colitis can make you feel like life is centered around your disease as you may be forced to sacrifice time with your loved ones daily due to your symptoms. On the other hand, home infusion therapy with ContinuumRx is the most non-disruptive way to effectively treat your symptoms. Your medication provides comfort while ContinuumRx gives you back your freedom.

Are you battling Crohn’s or colitis and are interested in receiving Remicade or Entyvio infusion therapy from home? Our team at ContinuumRx can answer any questions you may have and guide you through the home infusion process. Contact us today!

heart month

Helping heart failure patients and their families feel at ease.

According to the Heart Failure Society of America, nearly 6.5 million Americans over the age of twenty have heart failure. One major study even estimates there are 960,000 new cases each year. A heart failure diagnosis can be devastating for a family. ContinuumRx allows patients to be treated at home, lifting burdens both emotionally and financially.

How does home infusion therapy help patients with heart failure?

Extended hospital stays can be pricey, lonely, and detrimental to a patient’s overall well-being. Home infusion therapy makes it possible for a patient to be treated in the comfort of their home.

However, treatment of heart failure is complex. This is especially true for Stage D heart failure patients. These patients need drugs to sustain their heart function until they are able to get a transplant. In situations where a transplant is not possible, they also need consistent care to keep them comfortable in the last few months of life.

It is crucial to choose a home infusion provider with the experience to handle such cases. This is where ContinuumRx can help.

What are some services ContinuumRx offers heart failure patients?

Our team of healthcare professionals are trained in a variety of medical services. One of our many areas of expertise is postoperative treatment for heart transplant patients.

Following a heart transplant, a patient needs constant medical support for a successful recovery. In this case, they often face a lengthy hospital stay away from family and the solace of their household. With ContinuumRx, patients can recover from heart transplants and other cardiological procedures at home. 

After your procedure is completed, you can return home and our professional staff will schedule routine check-ups with you. They will keep a close monitor on your recovery process and administer drugs prescribed by your cardiologist. 

Inotropic therapy is another area we are well-versed in. In a 2015 study published by the International Journal of Molecular Sciences, inotropes were found to reduce the frequency of hospitalization and improve the symptoms of some severe heart failure patients. 

Inotropic therapy is often used to either strengthen or weaken a patient’s heartbeat as needed. Milrinone, dobutamine, and dopamine are all examples of inotropes which the professionals at ContinuumRx are skilled in administering. 

ContinuumRx performs these medical services with unparalleled care and dedication to our patients. If you or a loved one has heart failure, ContinuumRx could be the right home infusion therapy provider for you.

What regimen does ContinuumRx put in place for their heart failure patients?

There are seven key items that patients should do daily to improve their condition.

  1. Take medications as instructed.
  2. Follow a low-sodium diet.
  3. Stay active or become physically active.
  4. Take notice of sudden changes in your weight.
  5. Keep your follow-up appointments.
  6. Track your symptoms.
  7. Live a healthy lifestyle.

We coin these habits as the “lucky seven” and their incorporation into a patient’s daily routine can have a positive impact on their condition.

Stay safe and cared for at home.

It’s no secret that the pandemic has made the hospital environment even more stressful for many patients. Not to mention, visits from family can be infrequent and oftentimes non-existent now due to COVID restrictions. 

ContinuumRx makes it possible for patients to undergo treatment without leaving the comfort of their home. That means less time in the hospital and more time amongst loved ones.

It’s time to choose home infusion therapy for your cardiological care. Contact ContinuumRx to onboard your therapy today!

Contact ContinuumRx TODAY!

A safer and flexible option during COVID-19.

If you are currently receiving infusion or injection therapies in a hospital or physician’s office setting, now is the time to consider moving your service over to ContinuumRx. With 6 locations across Alabama, Tennessee, and Virginia, including two infusion suites in Knoxville, TN, and Chantilly, VA, our commitment is to provide the highest quality of care and make patients as comfortable and safe as possible during their treatments. 

Why should you consider our home infusion or visiting one of ContinuumRx’s infusion suites?

The answer is simple: 1) reducing the chances of contracting COVID-19, 2) having flexibility and quality of life, and 3) safety.

With COVID-19 on the rise and significant space being taken up in hospitals by patients, it makes sense to reduce the risk for infusion patients as they are typically immunocompromised and fall within the “at-risk” category. Even the basic, required tasks of going through pre-screening and emergency preparedness procedures at a hospital can increase risk and exposure rates for an infusion patient.

“Infusion therapy patients are vulnerable to infections and viruses like COVID-19, and ContinuumRx is providing a critical service during the pandemic as we relieve the burden on the hospitals during the unprecedented times while working to ensure that patients who need infusion therapy receive it in the safest manner,”

Carol Sweeney, Vice President of Nursing and Clinical Compliance, ContinuumRx

Flexibility and quality of life are two additional key factors to consider. ContinuumRx’s team works with its patients and their physicians to select a customized infusion therapy based on their condition, lifestyle, and time constraints. For higher-risk patients, especially those with chronic diseases who need to stay on course with managing their treatment, home infusion and infusion suites are comfortable and convenient alternatives where personalized care is heightened, and risk-exposure is reduced. 

Last is safety. ContinuumRx follows the same Centers for Disease Control and Prevention (CDC) protocols that hospital- and physician-based infusion centers are required to follow with the benefit of controlling the volume of patients. Below are some of the safety protocols that we follow:

General ContinuumRx Safety Protocols

  • Nursing staff has proper PPE at all times (i.e., face cover, gloves, and gown).
  • Temperature checks on all ContinuumRx staff.
  • Symptom checks on all ContinuumRx staff.
  • Quarantine and work-from-home for potentially exposed employees. 
  • Alerting nursing/warehouse + patients in the home about COVID-19 exposure. 
  • Contactless delivery.

Safety Protocols for ContinuumRx Infusion Suites

  • Facility cleaning before each shift. 
  • Suites are adequately segregated from home infusion pharmacy operations.
  • Chairs are set a minimum of 6 feet apart, and partitions are in place.
  • Suite staff is limited to essential staff to complete patient care safety.
  • Caregivers, family, friends, etc., are restricted during infusion.
  • Patients are scheduled at 50% capacity.
  • Screening tests are completed at least 24 hours prior to each visit and immediately prior to entering the suite.
  • Screenings occur prior to entering the suite to allow for decontamination as needed.
    • If a patient fails a screen, immediately cancel the appointment. Evaluate whether home infusion IS a viable alternative.
  • Ensure proper cleaning and disinfection is performed prior to and after each patient.
  • Have patients wait in their vehicles until their appointment time. Mobile

Next Steps?

The most important factor in your decision-making is to decide to put your health first. Add ContinuumRx to your New Year’s resolution list and know that you will receive the comfort, convenience, and care that you need and deserve.

Find a ContinuumRx Location Nearest You

home infusion therapy

Hospital at Home or (HaH) is a term that will quickly be added to the vocabulary of Americans due to the current pandemic. As reported by Fox Business on August 20th, “Across the U.S., “hospital at home” programs are taking off amid the pandemic, thanks to communications technology, portable medical equipment, teams of doctors, nurses, X-ray techs and paramedics.”1 Excitingly enough, the home infusion industry has been operating under the care-at-home mentality for decades. This affords patients that have both acute and chronic illnesses, and cannot be treated with oral medications, the ability to be treated safely and effectively from the comfort of their own homes.

Think about it, how many people do you know that have a chronic illness like rheumatoid arthritis, cancer, congestive heart failure, Crohn’s disease, multiple sclerosis, or ALS to name a few? Do they spend a multitude of time traveling to and from a healthcare facility to receive hours of treatment? Now layer on COVID-19, a virus that has proven to impact individuals with weakened immune systems, and you have a recipe for disaster.

If you had the option, would you choose for your loved ones to have a treatment option that would increase the quality of their care AND deliver some sense of normalcy in their life?

Prior to COVID-19, the home infusion industry was predominantly a B2B industry where a physician, nurse practitioner, and/or case manager kick-started the process. This is understandable, as there are many moving parts and seamless coordination that required between patients, physicians, hospital discharge planners, health plans, and of course, a home infusion pharmacy. Home infusion companies, like ContinuumRx, make the process seamless by coordinating all the pieces, including insurance approvals and payment plans to get patients into the right setting of care at the right time. But there is a recent shift as patients are learning about treatments online and are seeking out care on their own. Joe Malatesta, Executive Vice President of Sales at ContinuumRx stated, “We are seeing a significant increase in customers reaching out to us directly to learn more about our IVIG, cardiac, parenteral, enteral, and antibiotic therapies. This is giving us a greater opportunity to engage with our prospective patients and educate them about the benefits of home infusion therapy.”

Hence, here are three key benefits of selecting home infusion therapy:

  1. Risk Reduction and Improved Safety
    Less is more. Home-based treatment in a controlled environment with one-on-one treatment with a certified nurse has proven that home infusion therapy prevents unnecessary hospital admissions, shortens the length of a hospital stay, and avoids unnecessary readmissions. The key learning is to have the professionals come to you.
  2. Cost, Time + Quality of Care
    As they say, home is where the heart is. Well, the truth is that it’s where healing occurs too. A pilot study at Brigham and Women’s Hospital in Boston around the concept of Hospital at Home (HaH), concluded that care can be improved while reducing costs. According to the study, those patients that received at-home care had fewer lab orders, less imaging (like X-ray and MRI), had fewer consultations, and were more mobile, which resulted in a 70 percent lower readmission rate. The findings also indicated that at-home care patients had total costs that were almost 40 percent lower than for patients treated conventionally. Aside from the time, cost savings for travel, and wear and tear on a patient’s vehicle (and psyche), a home infusion patient benefits from being at home in a controlled environment that saves money and keeps them healthier.
  3. Medical Coverage
    The Centers for Medicare Medicaid Service (CMS) issued a proposed rule: CY 2021 Home Health Prospective Payment System Rate Update; Home Health Quality Reporting Requirements; and Home Infusion Therapy Service Requirements” (Proposed Rule). The NHIA has been working with stakeholders and legislators to advocate for Congress’ intended implementation of the 21st Century Cures Act.

    Find comfort in the numbers. According to the National Home Infusion Association, 3.2 million patients receive home infusion annually with 98% of patients reporting that they are very satisfied with their treatment. Connie Sullivan, President and CEO, National Home Infusion Association, commented that the role of the home infusion industry is, “Helping patients get back to normal life. They can take care of the medication, take care of their health, without having to focus on it and make their entire world revolve around it. It really allows us to bring those solutions to the patient, literally where they live.”3

Do you know someone that could benefit from home infusion therapy? Please contact ContinuumRx for more information @


1(2002, August 20). Coronavirus pandemic pushes expansion of ‘hospital at home’ treatment. At-home care aims to reduce strains on medical centers and ease patients’ fears. Retrieved from HERE.

2(2019, December 17). Being Treated at Home Can Help People Save Money and Heal Faster. Retrieved from HERE.

3(2020, August 12). NHIA: Representing Home and Specialty Infusion. Retrieved from YouTube HERE.

On average, approximately 34,000 patients in the United States receive parenteral nutrition (PN) each year1 for critical ailments. For patients 65+ who are on Medicare, the worst news that a physician or case manager has to deliver is, “I’m sorry, you don’t meet the Medicare criteria for home parenteral nutrition.”

For over 20 years, parenteral nutrition has fallen under the prosthetic device benefit under Medicare Part B. There are seven gastrointestinal conditions (GI) that are considered by Medicare before providing coverage. And when it can be proven that a patient permanently (beyond three months) cannot absorb nutrients that are needed to maintain their weight and strength, is when Medicare may cover the accessories or supplies that are needed for long-term home infusion therapy. Patients with short bowel syndrome, GI fistulas, bowel obstructions, acute pancreatitis, and/or nutritional complications from cancer are typical candidates. It goes without saying that the nutritional mix of protein, carbohydrate, fat, minerals and electrolytes, vitamins and other trace elements and are received through parenteral nutrition can reduce complications, and even more so, reduce the risk of rehospitalization. As a result, regardless of insurance coverage or not, if there is any possibility that a patient may require parenteral nutrition (PN) at home after being discharged, the planning and documentation process needs to start immediately. By starting right away, it ensures that the physician, case manager, infusion provider, as well as the patient, are aware of what is required to attempt to secure coverage.

Understanding what Medicare covers and does not cover will ensure speed, efficiency, and uninterrupted quality of care on behalf of the patient. Utilize and implement the guidelines and quick-reference chart below to maximize effectiveness.

Medicare Does Not Cover Parenteral Nutrition For

Patients with a functioning gastrointestinal tract whose need for parenteral nutrition is only due to any of the following conditions:

  • Swallowing disorder
  • Temporary defect in gastric emptying such as a metabolic or electrolyte disorder
  • Psychological disorder impairing food intake such as depression
  • Metabolic disorder inducing anorexia such as cancer
  • Physical disorder impairing food intake such as the dyspnea of severe pulmonary or cardiac disease
  • Side effect of a medication
  • Renal failure or dialysis

Medicare DOES Cover Parenteral Nutrition

(Parenteral Nutrition is approved on an individual, case-by-case basis initially and at periodic intervals of no more than three months by a Medicare Administrative Contractor (A/B MAC (B)) medical consultant or specially trained staff. It is expected that the patient’s medical records will reflect the need for the care provided. These records are not routinely submitted but must be available upon request.)

7 Gastrointestinal Conditions for Medicare Consideration

  1. Severe Short Bowel Resection: Surgery within the past three months, leaving less than 5 feet of small bowel beyond the ligament of the Treitz.
  2. Severe Short Bowel Syndrome: The patient has a short bowel syndrome that is severe enough that the patient has significant gastrointestinal fluid and electrolyte malabsorption.
  3. Bowel Rest for at Least 3 Months: The patient requires bowel rest for at least three months for treatment of:
    1. Symptomatic pancreatitis with/without pancreatic pseudocyst
    2. Severe exacerbation of regional enteritis
    3. A proximal enterocutaneous fistula where tube feeding distal to the fistula isn’t possible.
  4. Complete Mechanical Small Bowel Obstruction: The patient has complete mechanical small bowel obstruction where surgery is not an option.
  5. Malabsorption and Malnutrition: The patient is significantly malnourished (10% weight loss over three months or less and serum albumin less than or equal to 3.4 gm/dl) and has severe fat malabsorption.
  6. Motility Disturbance and Malnutrition: The patient is significantly malnourished (10% weight loss over 3 months or less and serum albumin less than or equal to 3.4 gm/dl) and has severe motility disturbance of the small intestine or stomach which is unresponsive to prokinetic medication.
  7. Malnourished and Proven Condition: The patient is malnourished (10% weight loss over three months or less serum albumin less than or equal to 3.4 gm/dl) and disease and the clinical condition has been documented as being present and it has not responded to altering the manner of delivery of appropriate nutrients (e.g., slow infusion of nutrients through a tube with the tip located in the stomach or jejunum).

The information provided is meant to be a guide for your information only. Each health care provider’s office is responsible for providing accurate information to ContinuumRx for verifying codes, coverage and payment policies used for individual patients to ensure that they are exact and appropriate for the services and items provided.

Contact a ContinuumRx Medicare qualifying expert or trained clinician to assess your patient’s eligibility.

1 Trends in Parenteral Nutrition, By Kristi L. King, MPH, RDN, CNSC, LD, Today’s Dietitian Vol. 21, No. 1, P. 36, January 2019.

home infusion

Currently, Medicare only covers certain home infusion drugs and biologicals administered intravenously, or subcutaneously, while commercial payors cover patients for an expansive array of intravenous and subcutaneous drugs. Lifting Medicare regulations, will ensure that Medicare enrollees in need of home infusion therapy can receive the care they need in a more comfortable environment and at a more reasonable cost to the federal government. This would provide increased access to care for patients with immune diseases, cancer, serious infections, heart failure, and other conditions that might otherwise force patients to receive their care in a more expensive and less convenient hospital, outpatient clinic, or skilled facility. This legislation is vital to home infusion patients, allowing them to safely receive treatment in the setting they overwhelmingly prefer—their homes.

“Home infusion providers have the capacity to treat hundreds-of-thousands of patients as hospitals and nursing facilities are being pushed to capacity,” said National Home Infusion Association (NHIA) Board Chair Logan Davis, PharmD, MBA. “Regardless of any change in policy, the home infusion community is working with health care providers to bring their resources to bare and keep the most vulnerable patients at home. While this can be a challenge for patients in traditional Medicare — where coverage is limited — the home infusion community is committed to playing a vital role in addressing this public health emergency.”

As per the NHIA, more than 160 hospitals, patient groups, and other stakeholders are calling on Medicare to lift restrictions on home infusion. They have announced their support for concept legislation that would: 

  • Cover Home Infusion Equipment, Supplies, and Professional Services.
  • Adequately Reimburse Providers.
  • Maintain Current Drug and Home Health Reimbursement.

“Our focus has always been to improve post-acute care coordination and care management, to help reduce gaps in patient care, and to enhance the overall patient experience,” said Keith Hartman, RPH, COO of ContinuumRx. “As a response to the pandemic, we have seen the rapid shift from moving care out of the hospital to home, are experiencing and measuring the success rates, and foresee that this is the model for the future. By lifting the current Medicare restrictions the door is opened to offer a higher quality of care and reduction in rehospitalization rates.”

ContinuumRx is committed to to doing our part to #FlattenTheCure, #DeliverHope, and heighten a patient’s quality of care while providing solutions to your staff and patients that require home infusion therapy. Our priority is to work with your team to identify patients that can be moved to the safety of their home not only to decrease their risk of hospitalization/re-hospitalization, but also to free up hospital beds for COVID-19 needs. 

We are actively monitoring the CDC guidelines related to the coronavirus (COVID-19) outbreak and updating our plans, policies, and guidelines as needed. We continue to accept and service new patients and operate under the highest standards.

ContinuumRx is dedicated to these guidelines to protect our healthcare providers and patients:

General Guidelines:

  • Complying with existing standard operating procedures (SOPs) and disaster emergency plans, and updating as needed for PPE modifications, social distancing, and compounding procedures.
  • Establish remote working capabilities for pharmacy staff where possible.

Patient Guidelines:

  • Providing bedside education and instruction via FaceTime, Zoom and Skype: 
    • For resumption of patient care 
    • For patients that are teachable remotely
    • Patient and caregiver education via video library
  • Requiring patients to wear face masks.
  • Maintain social distancing.
  • Comply with local health department screening, patient contact, and reporting requirements.

Patient Delivery:

  • Employ delivery strategies that limit patient/employee exposure:
    • Leave packages at the patient’s home and call the patient to alert them to delivery.
    • Utilize photo confirmation rather than obtain signatures.
    • Use common courier services (UPS, FedEx) whenever possible.
    • Do not allow courier or shipping personnel into your household.

Nursing Staff:

  • Limit nursing time in the home.
  • Medical-grade masks, gowns, and shoe covers.
  • Hand sanitizer upon initial entry and during glove change processes.
  • Instruct patients to have supplies needed for procedures ready prior to the nurse entering the home.
  • Nursing bags are prohibited in the patient’s home.
  • Limit non-disposable supplies taken into home.
  • Use disposable supplies, such as BP cuffs, stethoscopes and thermometer when possible.
  • Complete non-physical assessment telephonically.
  • Complete all documentation outside the home.
  • Patient Screening Tool to Identify COVID-19 Patients.
  • COVID-19 testing recommendations.
  • Isolation guidelines when employees develop symptoms.
  • Quarantine guidelines when exposure is suspected.
  • Return to work guidelines per CDC Criteria for Return to Work for Healthcare Personnel with Confirmed or Suspected COVID-19.

We will continue to implement innovative ways to maintain the same level of service that you expect as we all work together during this difficult time.